Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint Acquires Kenna Technologies in All-Stock Deal

NEW YORK, Nov. 1 (GenomeWeb News) - DNAPrint Genomics acquired privately held Kenna Technologies in an all-stock transaction, DNAPrint said today.


Shareholders of the West Chester, PA-based company exchanged all of their outstanding shares for 1.5 million shares of DNAPrint's common stock. The transaction took effect Oct. 25.


With the acquisition, DNAPRint gains Kenna's BoneFusion and CellCycleFusion models. BoneFusion simulates processes in bone remodeling and CellCycleFusion simulates molecular pathways that control basic cellular functions.


This is DNAPrint's second major acquisition for the year. The company acquired Trace Genetics in June and 18% of Biofrontera in July.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.